Richard A. Barasch
Director · Starling Oncology, Inc.
Individual
- 2024
- Aug 12, 2025
- 4
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Richard A. Barasch files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jorey Chernett - $2.69M in STLN purchases and sales in the last 12 months
- Brad Hively - $2.00M in STLN purchases and sales in the last 12 months
- Mohit Kaushal - $335K in STLN purchases and sales in the last 12 months
- Yale Podnos - $276K in STLN purchases and sales in the last 12 months
- Mark L. Pacala - $200K in STLN purchases and sales in the last 12 months
- Robert Ross Carter - $879 in STLN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Richard A. Barasch?
Richard A. Barasch is a corporate insider, tracked as Director of Starling Oncology, Inc. (STLN). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Richard A. Barasch last file a Form 4?
The most recent primary Form 4 on record is dated 12 August 2025, one of 4 filings going back to 2024.
